Friday, November 23, 2007

Thalidomide resurfaces as treatment for multiple myeloma

From CBC News:
A derivative of thalidomide may prolong life in people with a type of bone marrow cancer called multiple myeloma — if taken with a steroid — a new study finds.

Called lenalidomide, the drug, in combination with the steroid dexamethasone, can slow the progress of the incurable bone marrow cancer and extend the lives of patients with the condition by an average of 10 months, the research suggests.

Multiple myeloma is a cancer of a type of white blood cell in the bone marrow. It is the second most prevalent blood cancer after non-Hodgkin's lymphoma, according to Myeloma Canada, with approximately 14,000 newly diagnosed cases in the United States annually. ...more

No comments: